BioAge Labs, Inc. Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the BIOA Class Action
17 janv. 2025 17h29 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
PCRX Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Pacira BioSciences, Inc.
17 janv. 2025 17h29 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that Pacira BioSciences, Inc. (PCRX) Failed to Disclose its Lack of Patent Protection for Exparel
USPTO Grants BetterLife’s BETR-001 Composition of Matter Patent
14 janv. 2025 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
MGP Ingredients, Inc. Shareholders are Encouraged to Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the MGPI Class Action
13 janv. 2025 21h23 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that MGP Ingredients, Inc. (MGPI) Misled Investors Regarding Demand and Inventory Levels
BIOA Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against BioAge Labs, Inc.
13 janv. 2025 20h39 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
AZN Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the AstraZeneca PLC Class Action
13 janv. 2025 19h49 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that AstraZeneca PLC (AZN) Misled Investors Regarding its Legal Exposure in China
Stockholder Notice: Robbins LLP Informs Stockholders of the BioAge Labs, Inc. Class Action
08 janv. 2025 18h46 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
BetterLife Announces Favorable Outcome in New York Legal Claims
09 déc. 2024 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of...
Music Licensing, Inc. (OTC: SONG) Announces Additional Royalty Payment from Listerine® Intellectual Property Stake, $36 Million to $250 Million Acquisition Targets for 2025, and Strategic Investor Relations Initiatives
02 déc. 2024 08h00 HE
|
Music Licensing, Inc.
Naples, FL, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG) (“the Company”) is pleased to announce the receipt of another royalty payment from its intellectual property stake...
BetterLife Obtains Favourable Cardiac Safety Data for BETR-001
25 nov. 2024 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...